Ocuphire Pharma, Inc. (OCUP) Financials
Stock symbol OCUP is outdated, potentially delisted? Maybe it is available on other exchange?
OCUP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 44.8 million | 4.2 million |
| March 31, 2024 | 51.8 million | 5.8 million |
| Dec. 31, 2023 | 53.9 million | 4.0 million |
| Sept. 30, 2023 | 54.2 million | 3.9 million |
OCUP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | -7.3 million | 806000 |
| March 31, 2024 | -5.7 million | 985000 |
| Dec. 31, 2023 | 4.5 million | 711000 |
| Sept. 30, 2023 | -3.0 million | 573000 |
OCUP Net Income
No data available :(
OCUP Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 41.4 million | - | - |
| March 31, 2024 | 47.2 million | - | - |
| Dec. 31, 2023 | 50.5 million | - | - |
| Sept. 30, 2023 | 42.4 million | - | - |
OCUP Shares Outstanding
OCUP Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | - | 6.1 million | 3.4 million | 9000 |
| March 31, 2024 | - | 4.7 million | 4.7 million | - |
| Dec. 31, 2023 | - | 3.8 million | 3.3 million | -3000 |
| Sept. 30, 2023 | - | 3.5 million | 2.1 million | - |
OCUP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | 1.1 million | 280000 |
| March 31, 2024 | 1.7 million | 4.7 million |
| Dec. 31, 2023 | 1.7 million | 3000 |
| Sept. 30, 2023 | 11.9 million | 1000 |
OCUP
Price: $1.17
52 week price:
Earnings Per Share: -0.54 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 340500
Market Capitalization: 31.7 million